Skip to main content
Header Nav
  • About
    • About Us
    • Vision and Values
    • Meet the Team
  • Products
  • Pipeline
  • Impact
  • Investors
  • Careers
  • Contact us
Specializing in Injectables
Header Nav
  • About
    • About Us
    • Vision and Values
    • Meet the Team
  • Products
  • Pipeline
  • Impact
  • Investors
  • Careers
  • Contact us
Investors Menu
Investor Relations
  • Investor Center Home
  • Press Releases
  • Corporate Governance
    • Board of Directors
    • Leadership Team
    • Policies and Charters
    • Board Committee Assignments
  • Stock Information
    • Stock Quote
    • Stock Chart
    • Historical Stock Quote
    • Investment Calculator
  • SEC Filings
  • Events & Presentations
  • Annual Reports
  • Analyst Coverage
  • Investor FAQs
  • Contact IR

Press Releases

Press Releases

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Eagle Pharmaceuticals to Present at J.P. Morgan 34th Annual Healthcare Conference
12/29/15
Eagle Pharmaceuticals Announces FDA Approval of Docetaxel Injection, Non-Alcohol Formula
12/24/15
Eagle Pharmaceuticals Reports Successful Outcomes from Safety and Efficacy Study of RYANODEX for Exertional Heat Stroke
12/17/15
Teva Pharmaceuticals and Eagle Pharmaceuticals Announce FDA Approval of BENDEKA™ (bendamustine hydrochloride) Injection
12/8/15
Eagle Pharmaceuticals Achieves Milestone to Receive $15 Million Payment for Approval of BENDEKA
12/8/15
Eagle Pharmaceuticals to Present at Piper Jaffray 27th Annual Healthcare Conference
11/23/15
Eagle Pharmaceuticals to Present at November Conferences
11/12/15
Eagle Pharmaceuticals, Inc. Reports Third Quarter 2015 Results
11/11/15
Eagle Pharmaceuticals and Spectrum Pharmaceuticals Announce Co-Promotion Agreement
11/4/15
Eagle Pharmaceuticals to Discuss Third Quarter 2015 Financial Results on November 11, 2015
10/29/15
Pagination
  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Next page
  • Last page
Change % Volume Data as of 09/11/2023 7:04 PM EDT Data Provided by Refinitiv. Minimum 15 minutes delayed.
Investor Relations
  • Investor Center Home
  • Press Releases
  • Corporate Governance
    • Board of Directors
    • Leadership Team
    • Policies and Charters
    • Board Committee Assignments
  • Stock Information
    • Stock Quote
    • Stock Chart
    • Historical Stock Quote
    • Investment Calculator
  • SEC Filings
  • Events & Presentations
  • Annual Reports
  • Analyst Coverage
  • Investor FAQs
  • Contact IR
Sidebar Links
  • Email Alerts
  • RSS Feeds

Investor Contact

In-Site
Communications, Inc.
Lisa M. Wilson,
212-452-2793

For all other media inquiries, please contact us.

Footer Links
  • privacy policy
  • terms of use
  • sitemap
  • contact us

© 2023 Eagle Pharmaceuticals, Inc. All rights reserved. Woodcliff Lake, NJ 07677